Chai brews up $400M series C to fuel AI molecule models used by Lilly, Novartis and Pfizer
Chai Discovery has continued its whirlwind emergence, closing its third financing round in 11 months to bring its total funding haul above $600 million. The latest round values the startup at $3.8…
Read the full articleYou might also wanna read
Chai Discovery Announces $400M Series C to Advance AI-Driven Molecular Design
Chai Discovery, the company engineering AI models to discover new molecules led by Joshua Meier and Matthew McPartlon, has announced a $400M
Chai Discovery triples to $3.8B in 7 months as OpenAI-backed drug designer lands $400M after Novartis deal
Chai Discovery has raised $400 million in a Series C round that values the AI drug discovery company…
AI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuation
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 m
forbes.com·1mo agoOpenAI Researcher in Talks to Launch AI Drug Discovery Startup at $2B Valuation
Miles Wang, a researcher at OpenAI, is reportedly in discussions to launch a new startup focused on AI-driven drug discovery. The venture is
OpenAI researcher Miles Wang leaves to launch AI drug discovery startup at $2B valuation
Lightspeed is in discussions to lead the funding round, sources say.
TechCrunch·14h agoOpenAI researcher Miles Wang leaves to launch AI drug discovery startup at $2B valuation
Lightspeed is in discussions to lead the funding round, sources say.
techcrunch.com·14h ago
Anaconda Secures $150M in Series C Funding to Strengthen AI Enterprise Solutions
With Insight Partners-led Round, Anaconda Establishes Role as the Standardized Python Distribution for Mission-Critical AI Systems
anaconda.com·11mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.